investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy
Christopher S Garris
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Christopher S Garris
Harvard University
Cambridge, United States
Related projects
Jeffrey Schlom
Strategies for Cancer Vaccine Development: Preclinical Studies
Trachea, bronchus and lung
Pathology
Curtis Harris
Biomarkers in Cancer Diagnosis, Prognosis, and Therapeutic Outcome
Trachea, bronchus and lung
Pediatric oncology or childhood cancer
Pathology
Piro Lito
Elucidating the regulation of mitosis by BRAF V600E in lung cancer
Trachea, bronchus and lung
Jonathan M Kurie
Regulation of Lung Cancer Metastasis by miR-200
Trachea, bronchus and lung
Martin Mcintosh
Profiling cancer neoantigen repertoires and validating immunotherapy targets
Trachea, bronchus and lung
Jeffrey Gildersleeve
Serum Antibody Profiling with a Carbohydrate Microarray
Trachea, bronchus and lung
Pathology
Eric Alejandro Sweet-Cordero
Novel effectors of Kras in oncogenesis, senescence and tumor progression
Trachea, bronchus and lung
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Trachea, bronchus and lung
Ethan Dmitrovsky
Targeting Anaphase Catastrophe to Combat Lung Cancer
Trachea, bronchus and lung